GSK: To invest £400 million in the UK over the next three years
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
```htmlGolden Ten Data July 28｜GlaxoSmithKline announced on Tuesday that it will invest 400 million pounds (approximately 531.12 million US dollars) in the UK over the next three years. The investment plan includes building a brand new R&D center in Cambridge. The company stated that this investment is an important part of accelerating the new drug development program under the leadership of the new CEO Luke Miels.```
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
BlackRock lifts Lanxess voting rights to 5.01% from 4.21%
Reuters•2026/08/17 13:44
JOST Werke starts trading on OTCQX Best Market in US under JSTWF ticker
Reuters•2026/08/17 13:44
BMV suspends AvalonBay Communities shares on Global Market SIC Capitales after NYSE halt
Reuters•2026/08/17 13:41
Crypto prices
More
Bitcoin
BTC
$63,547.71
+0.87%
Ethereum
ETH
$1,901.44
+1.17%
Tether USDt
USDT
$0.9988
-0.01%
USDC
USDC
$0.9998
-0.01%
XRP
XRP
$1
+0.16%
Solana
SOL
$75.54
+0.32%
TRON
TRX
$0.3316
-0.02%
Hyperliquid
HYPE
$59.15
+3.57%
Dogecoin
DOGE
$0.07015
+0.40%
Zcash
ZEC
$512.05
+5.24%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now